JUN 21, 2018 5:25 AM PDT

The Silver Tsunami: An Aging Immune System and Cancer

WRITTEN BY: Kara Marker

Why do cases of cancer become more common as we get older? Scientists interested in explaining the so-called “Silver Tsunami” phenomenon look to immune cells for an answer. From Monash University, researchers show how age-related inflammation, or “inflamm-aging,” could be to blame for increased incidence of cancer as people get older.

Life expectancy in the United States and worldwide is significantly higher than it was half a century ago. Experts estimate that by 2050, more than 20 percent of the population will be older than 65. This means that over 20 percent of the population will be at an increased risk of cancer, all because weak immune cells grow in number and strong immune cells fade away.

Specifically, Monash University scientists describe “virtual memory T cells” and “true naïve T cells.” The former are prone to losing their ability to become activated, leaving them essentially useless in fighting pathogens and preventing cancer. Researchers found that these cells make up just five percent of T cells in young animal models and younger humans, but they increase significantly with old age.

True naïve T cells, unlike virtual memory T cells, keep their ability to become activated and participate in an immune response, but this population of cells decreases significantly as people get older. Researchers found that these cells go from 90 percent of the T cell population to just 30 percent. So as people age, they lose the cells that they need to fight off infection and prevent cancer, and they gain the cells too weak to put up a fight.

Accumulation of the virtual memory T cell population paired with the progressive loss of true naïve T cells is the perfect storm to explain the increased incidence of cancer associated with older age. Additionally, these changes prevent older people from mounting an effective immune response to vaccines, and reduce the chances of success with cancer immunotherapy.

"In cancer immunotherapy, a patient's own T cells are stimulated to kill cancer cells and it has been hugely successful for certain forms of cancer,” explained Nicole La Gruta. “Unfortunately, older patients or people over 65 years of age respond less well than younger ones.”

A potential solution is to selectively target each population of T cells to reduce the incidence of cancer in older people. For example, reduce the amount of virtual memory T cells and/or increase the amount of true naïve T cells. This approach could improve treatment and prevention of cancer.

“We may be able to tailor cancer immunotherapy specifically for the needs of an older patient's immune system- this is where medicine must head to meet the needs of our ageing society,” La Gruta explained.

Norman E. Sharpless, MD, wrote about cancer and aging in a January Cancer Currents Blog: “It’s clear that we need to better understand how the biological underpinnings of aging affect the onset and trajectory of cancer to address this looming public health challenge.”

The present study was published in the journal Cell Reports.

Sources: National Cancer Institute, Monash University

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
NOV 12, 2019
Immunology
NOV 12, 2019
Allergy Shots May Work for Kids with Pollen Food Allergy Syndrome
It’s not common for young children to develop pollen food allergy syndrome (PFAS), but for those that do, there’s not too much parents can do o...
DEC 04, 2019
Immunology
DEC 04, 2019
Predicting Death with Clinical Immune Indicators
Immune and inflammation status could help doctors predict which individuals are most at-risk for death. Results from a new study mark the first step toward...
DEC 16, 2019
Drug Discovery & Development
DEC 16, 2019
Vaccine To Protect Against The Zika Virus
Scientists at The University of Texas Medical Branch at Galveston present for the first time how a single high dose vaccine can protect a pregnant mouse al...
JAN 14, 2020
Technology
JAN 14, 2020
Can Virtual Reality Influence an Increase in Vaccinations?
Can a virtual reality (VR) help increase flu vaccination rates? Apparently, yes! A recent study using VR stimulation is aiming to show how the flu spreads ...
FEB 13, 2020
Immunology
FEB 13, 2020
Protein that suppresses immune system linked to lupus
  A study published in Human Immunology has described, for the first time, a link between an immunosuppressive protein on the surface of T cells and t...
FEB 10, 2020
Immunology
FEB 10, 2020
How Cancer Evades the Immune System Time and Time Again
Scientists discovered a new mechanism by which cancer cells evade the immune system to further their own agenda: invade, multiply, and spread. Identifying...
Loading Comments...